Navigation Links
Agency Take-up Soars of Agnitio's Leading Pull Marketing Platform for the Healthcare Industry
Date:1/17/2013

COPENHAGEN, Denmark, January 17, 2013 /PRNewswire/ --

  • 50% jump in licences over the last two months
  • Used by leading global agencies

A rapid increase in interest around Agnitio's closed loop marketing platform, has seen the global pharmaceutical marketing company experience a 50% increase in the number of licences granted to advertising, marketing and creative agencies in the last two months alone.

     (Logo: http://photos.prnewswire.com/prnh/20120924/562917-a)
     (Photo: http://photos.prnewswire.com/prnh/20120924/562917-b )

Already used by several of the leading global agencies including Publicis, CDM and Draftfcb, the Agnitio platform has the advantage of being quicker, more flexible and far less resource heavy than other options available. Agencies with rights to the platform can easily create rich content, upload it, share it with their clients and then test it.

"As well as providing the best-in-class pull marketing platform to global healthcare companies directly, we are finding that their agencies are increasingly embracing our platform," says Morten Hjelmsoe, Founder and CEO of Agnitio. "In an ever more competitive healthcare market, the Agnitio platform has the key assets of speed, ease and flexibility to allow pharma companies and their agencies to personalise and optimise interactions with their customers, maximising time and building trusted relationships."

Agnitio licences allow users to create, upload and distribute presentations. They can also facilitate the approval of any new presentation before publishing to the iPad and allow the agency to check that the presentation is generating the correct data in line with its clients' requirements. Based on HTML5, the platform is excellent for localising content and importantly negates the need and desire to produce numerous independent apps, leading to unrelated content which is both costly and difficult to control.

Headquartered in Denmark, with regional hubs in the United States, Latin America and China, Agnitio works for major firms including Bayer, Roche and Takeda, to help generate effective relationships with healthcare professionals via its platform. Through understanding doctors' individual needs and interests, highly relevant and precisely targeted information and services can be provided quickly and easily.

About Agnitio

Agnitio helps pharmaceutical and medical device companies generate effective relationships with medical professionals. The provider of the leading pull marketing software platform for the pharmaceutical and medical device industries, Agnitio's system is already implemented in more than 45 countries and 25 languages - and used by major pharmaceutical and medical device companies including: Takeda, MSD, Amgen, Roche and Bayer.


'/>"/>
SOURCE Agnitio
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
2. UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
3. DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone
4. Awareness of Omega-3 Benefits Soars
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. BioSpace Spotlights Leading Life Science Community
7. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
8. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
9. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
10. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
11. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 22, 2016 Cell Applications, Inc. and ... to produce up to one billion human induced ... one week. These high-quality, consistent stem cells enable ... and spend more time doing meaningful, relevant research. ... high-volume manufacturing process that produces affordable, reliable HiPSC ...
(Date:6/22/2016)... --  StockNewsNow.com , The Official MicroCap News Source™, today ... Pourhassan , President & CEO of CytoDyn Inc. (OTCQB: ... and potential commercialization of humanized monoclonal antibodies for the ... company,s website (see here: www.CytoDyn.com ). The video ... 2016, at the LD Micro Invitational in ...
(Date:6/22/2016)... ... ... New light-based technologies that facilitate a “look inside” the human body using ... wearable devices for point-of-care diagnostics as well as powerful new systems that provide even ... future directions are detailed in a new open-access article by Antonio Pifferi and colleagues ...
(Date:6/22/2016)... ALBANY, N.Y. , June 22, 2016 /PRNewswire/ ... Research, Inc. (NASDAQ: AMRI ) today ... produce and sell the first commercially available cannabichromene ... is manufactured using Teewinot,s patented biosynthetic processes. Teewinot,s ... genes in microorganisms for efficient production of large ...
Breaking Biology Technology:
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):